FierceBiotech4h
Pfizer axes B7-H4 ADC, triggering $1B impairment charge as blockbuster vision evaporates
Pfizer has taken a $1.2 billion hit after reassessing the prospects of two antibody-drug conjugates (ADC) it picked up in the ...
NYC Project to Convert Former Pfizer Headquarters Lands $135 Million Loan
The effort to convert Pfizer Inc.’s former New York headquarters into residences secured financing to help developers forge ...
devdiscourse4h
Key Developments in Global Health: Merck, Pfizer, and Innovative Vaccines
This update provides insights into critical global health developments, including Merck's halt on Gardasil shipments to China ...
Pfizer: Q4 Earnings Snapshot
Pfizer expects full-year earnings in the range of $2.80 to $3 per share, with revenue in the range of $61 billion to $64 billion. This story was generated by Automated Insights ( ...
Pfizer Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Analysts expect the New York-based company to report quarterly earnings at 46 cents per share, up from 10 cents per share in ...
archpaper3d
Gensler to convert old Pfizer World Headquarters in Manhattan to housing
The work underway at the former Pfizer headquarters marks a significant addition to Gensler’s office-to-residential ...
David Werner, Metro Loft land $135M loan for Pfizer HQ conversion
Northwind Group provided $135 million to the Ndevelopers for their 1,500-unit redevelopment in Midtown Manhattan.
Pfizer to pay $59.7 million over kickbacks for migraine drug
Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...
Pfizer’s BRAFTOVI® Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the ...